These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 2842472)

  • 1. Evaluation of cyclosporine nephrotoxicity in rats with various renal radioactive agents.
    McAfee JG; Thomas FD; Subramanian G; Roskopf M; Hellwig B
    J Nucl Med; 1988 Sep; 29(9):1577-81. PubMed ID: 2842472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of diffuse glomerular lesions in rats: I. Comparisons of conventional radioactive agents.
    McAfee JG; Thomas FD; Subramanian G; Lyons B; Roskopf M
    J Nucl Med; 1986 Apr; 27(4):502-12. PubMed ID: 3012028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different radioactive renal agents in cisplatin-induced tubular toxicity in rats.
    McAfee JG; Subramanian G; Thomas FD; Hellwig B; Roskopf M
    J Nucl Med; 1989 May; 30(5):659-65. PubMed ID: 2715830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of renal concentration of technetium-99m glucoheptonate.
    Lee HB; Blaufox MD
    J Nucl Med; 1985 Nov; 26(11):1308-13. PubMed ID: 2997418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal radiopharmaceuticals--an update.
    Chervu LR; Blaufox MD
    Semin Nucl Med; 1982 Jul; 12(3):224-45. PubMed ID: 6289454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal function and imaging studies.
    Dubovsky EV
    Clin Nucl Med; 1981 Oct; 6(10S):P46-54. PubMed ID: 6271442
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of nuclear medicine in clinical urology and nephrology.
    Blaufox MD; Fine E; Lee HB; Scharf S
    J Nucl Med; 1984 May; 25(5):619-25. PubMed ID: 6327945
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of different radioactive agents for the detection of renovascular hypertension with captopril in a rat model.
    McAfee JG; Kopecky RT; Thomas FD; Hellwig B; Roskopf M
    J Nucl Med; 1988 Apr; 29(4):509-15. PubMed ID: 3280751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current status of renal radiopharmaceuticals. A review.
    Blaufox MD
    Contrib Nephrol; 1987; 56():31-7. PubMed ID: 3038466
    [No Abstract]   [Full Text] [Related]  

  • 10. Radionuclide renal imaging in the United States.
    Gates GF
    Eur J Nucl Med; 1995 Sep; 22(9):1081-4. PubMed ID: 7588949
    [No Abstract]   [Full Text] [Related]  

  • 11. [Quantification of separate renal function using Tc 99m DTPA and Tc 99m DMSA. Correlations between individual isotopic data and creatinine clearance].
    Chevet D; Moisan A; Le Pogamp P; Le Cloirec J; Wehbe B; Herry JY
    Nephrologie; 1984; 5(1):21-5. PubMed ID: 6328339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor technetium-99m-DMSA renal uptake with near normal technetium-99m-DTPA uptake caused by tubulointerstitial renal disease.
    Quinn RJ; Elder GJ
    J Nucl Med; 1991 Dec; 32(12):2273-4. PubMed ID: 1660540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
    Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE
    J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of renograms with simultaneous injection of 99mTc-DTPA and 131I-OIH--estimation of GFR, ERPF and retention function of individual kidney].
    Maeda M; Hasegawa R; Tanaka S; Yoshida H
    Kaku Igaku; 1985 Sep; 22(9):1341-52. PubMed ID: 3910897
    [No Abstract]   [Full Text] [Related]  

  • 15. Imaging in acute renal infection in children.
    Daly MJ
    AJR Am J Roentgenol; 1987 Jul; 149(1):206. PubMed ID: 3035908
    [No Abstract]   [Full Text] [Related]  

  • 16. Technetium-99m DTPA renal flow studies in Goldblatt hypertension.
    Nally JV; Clarke HS; Windham JP; Grecos GP; Gross ML; Potvin WJ
    J Nucl Med; 1985 Aug; 26(8):917-24. PubMed ID: 3897482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A.
    Klintmalm GB; Klingensmith WC; Iwatsuki S; Schröter GP; Starzl TE
    Radiology; 1982 Jan; 142(1):199-202. PubMed ID: 7031760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA].
    Lepej J; Marosová A; Kliment J; Buchanec J; Svitác J; Klisenbauer L
    Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the renal clearance of 99mTc-DTPA and inulin, 131I-hippurate and PAH and creatinine clearance in Wistar rats].
    Hagemann J; Su LM; Strangfeld D; Schürer M; Siewert H; Pietsch R; Kruse I; Priem F
    Radiobiol Radiother (Berl); 1988; 29(4):497-505. PubMed ID: 3055016
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential renal uptake of technetium-99m-DMSA and technetium-99m-DTPA.
    De Geeter F; Saelens E; Van Steelandt H; Degomme P
    J Nucl Med; 1993 Jul; 34(7):1217-8. PubMed ID: 8391071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.